Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Flavonoids | 15 | 2022 | 445 | 1.860 |
Why?
|
| Anthocyanins | 7 | 2022 | 80 | 0.860 |
Why?
|
| Flavonols | 5 | 2020 | 85 | 0.860 |
Why?
|
| Isoflavones | 7 | 2008 | 136 | 0.740 |
Why?
|
| Diet | 22 | 2022 | 8074 | 0.710 |
Why?
|
| Estrogens, Non-Steroidal | 3 | 2003 | 52 | 0.630 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2014 | 190 | 0.420 |
Why?
|
| Trans Fatty Acids | 1 | 2014 | 155 | 0.410 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2014 | 540 | 0.360 |
Why?
|
| Plants | 1 | 2008 | 327 | 0.280 |
Why?
|
| Dietary Fats | 2 | 2016 | 1994 | 0.280 |
Why?
|
| Soy Foods | 2 | 2006 | 44 | 0.280 |
Why?
|
| Flavanones | 4 | 2015 | 74 | 0.270 |
Why?
|
| Premenopause | 3 | 2006 | 1039 | 0.270 |
Why?
|
| Metabolome | 3 | 2019 | 987 | 0.270 |
Why?
|
| Body Composition | 3 | 2014 | 2422 | 0.260 |
Why?
|
| Flavones | 3 | 2020 | 68 | 0.260 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 1808 | 0.250 |
Why?
|
| Fruit | 3 | 2019 | 1160 | 0.220 |
Why?
|
| Genistein | 1 | 2003 | 86 | 0.210 |
Why?
|
| Lignans | 3 | 2014 | 84 | 0.210 |
Why?
|
| Soybean Proteins | 1 | 2003 | 55 | 0.210 |
Why?
|
| Adiponectin | 1 | 2008 | 1113 | 0.210 |
Why?
|
| Tea | 2 | 2020 | 288 | 0.190 |
Why?
|
| Vitamin B 6 | 1 | 2022 | 234 | 0.180 |
Why?
|
| Fragaria | 1 | 2019 | 21 | 0.170 |
Why?
|
| Nutrition Assessment | 6 | 2020 | 728 | 0.170 |
Why?
|
| Muscle, Skeletal | 2 | 2014 | 4946 | 0.160 |
Why?
|
| Biological Availability | 3 | 2006 | 390 | 0.160 |
Why?
|
| Eating | 3 | 2016 | 1538 | 0.160 |
Why?
|
| Postmenopause | 3 | 2008 | 2513 | 0.150 |
Why?
|
| Inflammation | 2 | 2015 | 10762 | 0.150 |
Why?
|
| Diet Records | 3 | 2020 | 427 | 0.150 |
Why?
|
| Phthalic Acids | 1 | 2022 | 478 | 0.140 |
Why?
|
| Patient Compliance | 2 | 2018 | 2690 | 0.140 |
Why?
|
| Phenols | 2 | 2011 | 517 | 0.140 |
Why?
|
| Diet Surveys | 1 | 2020 | 1162 | 0.130 |
Why?
|
| Pulmonary Ventilation | 1 | 2018 | 372 | 0.130 |
Why?
|
| Pyrus | 1 | 2015 | 13 | 0.130 |
Why?
|
| Food, Fortified | 2 | 2008 | 189 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2021 | 12143 | 0.130 |
Why?
|
| Feeding Behavior | 6 | 2021 | 3187 | 0.130 |
Why?
|
| Phytoestrogens | 3 | 2006 | 59 | 0.120 |
Why?
|
| Potassium, Dietary | 1 | 2015 | 103 | 0.120 |
Why?
|
| Estrogen Receptor beta | 2 | 2006 | 168 | 0.120 |
Why?
|
| Malus | 1 | 2015 | 50 | 0.120 |
Why?
|
| Diet, Mediterranean | 2 | 2018 | 740 | 0.120 |
Why?
|
| 4-Butyrolactone | 1 | 2014 | 61 | 0.110 |
Why?
|
| Denmark | 3 | 2021 | 771 | 0.110 |
Why?
|
| Milk | 1 | 2016 | 443 | 0.110 |
Why?
|
| Cholecalciferol | 1 | 2018 | 553 | 0.110 |
Why?
|
| Motor Activity | 2 | 2015 | 2711 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2020 | 1535 | 0.110 |
Why?
|
| Middle Aged | 26 | 2022 | 220826 | 0.110 |
Why?
|
| Environmental Pollutants | 1 | 2022 | 1276 | 0.100 |
Why?
|
| Plant Preparations | 2 | 2003 | 94 | 0.100 |
Why?
|
| Osteoporosis, Postmenopausal | 2 | 2008 | 396 | 0.100 |
Why?
|
| Prospective Studies | 14 | 2022 | 54415 | 0.100 |
Why?
|
| Dietary Supplements | 3 | 2019 | 3414 | 0.100 |
Why?
|
| Intestinal Absorption | 2 | 2003 | 400 | 0.100 |
Why?
|
| Absorptiometry, Photon | 3 | 2014 | 1737 | 0.100 |
Why?
|
| Ascorbic Acid | 1 | 2015 | 655 | 0.100 |
Why?
|
| Cross-Sectional Studies | 6 | 2021 | 26112 | 0.100 |
Why?
|
| Female | 33 | 2022 | 392581 | 0.100 |
Why?
|
| Body Mass Index | 5 | 2016 | 12951 | 0.100 |
Why?
|
| Glaucoma | 1 | 2021 | 1185 | 0.090 |
Why?
|
| Humans | 44 | 2024 | 761423 | 0.090 |
Why?
|
| Energy Intake | 2 | 2015 | 2134 | 0.090 |
Why?
|
| Risk Factors | 15 | 2022 | 74167 | 0.090 |
Why?
|
| Adult | 21 | 2022 | 221148 | 0.080 |
Why?
|
| Lipids | 1 | 2020 | 3340 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2024 | 22168 | 0.080 |
Why?
|
| Obesity | 4 | 2021 | 12938 | 0.080 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 2110 | 0.080 |
Why?
|
| Multivariate Analysis | 4 | 2015 | 12058 | 0.080 |
Why?
|
| Osteoporosis | 1 | 2018 | 1605 | 0.080 |
Why?
|
| Sarcopenia | 1 | 2014 | 372 | 0.080 |
Why?
|
| Incidence | 7 | 2022 | 21341 | 0.080 |
Why?
|
| Linear Models | 2 | 2016 | 5869 | 0.080 |
Why?
|
| Aged | 17 | 2022 | 169235 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 10766 | 0.080 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2009 | 160 | 0.070 |
Why?
|
| Male | 23 | 2022 | 360736 | 0.070 |
Why?
|
| Parkinson Disease | 1 | 2022 | 2877 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3204 | 0.070 |
Why?
|
| Epidemiology | 1 | 2010 | 279 | 0.070 |
Why?
|
| Cardiovascular Diseases | 5 | 2019 | 15498 | 0.070 |
Why?
|
| Thiocyanates | 1 | 2006 | 70 | 0.070 |
Why?
|
| Glioma | 1 | 2021 | 3455 | 0.070 |
Why?
|
| Cognition | 1 | 2024 | 6986 | 0.070 |
Why?
|
| Proportional Hazards Models | 5 | 2021 | 12456 | 0.070 |
Why?
|
| Brain Ischemia | 1 | 2019 | 3049 | 0.070 |
Why?
|
| Cohort Studies | 8 | 2021 | 41446 | 0.060 |
Why?
|
| Neoplasms | 4 | 2022 | 22164 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2020 | 8487 | 0.060 |
Why?
|
| Anticarcinogenic Agents | 1 | 2006 | 250 | 0.060 |
Why?
|
| Nutrition Surveys | 2 | 2022 | 1728 | 0.060 |
Why?
|
| Sulfates | 1 | 2005 | 380 | 0.060 |
Why?
|
| Follow-Up Studies | 7 | 2022 | 39117 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2019 | 3407 | 0.060 |
Why?
|
| Bone and Bones | 2 | 2018 | 2568 | 0.050 |
Why?
|
| Life Style | 2 | 2019 | 3914 | 0.050 |
Why?
|
| Antioxidants | 1 | 2011 | 1669 | 0.050 |
Why?
|
| Chromans | 1 | 2003 | 117 | 0.050 |
Why?
|
| Infant Food | 1 | 2003 | 140 | 0.050 |
Why?
|
| Metabolic Clearance Rate | 1 | 2003 | 361 | 0.050 |
Why?
|
| Self Report | 3 | 2021 | 3724 | 0.050 |
Why?
|
| Aged, 80 and over | 7 | 2022 | 58956 | 0.050 |
Why?
|
| Plasticizers | 1 | 2022 | 52 | 0.050 |
Why?
|
| Pyridoxal Phosphate | 1 | 2022 | 125 | 0.050 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2003 | 353 | 0.050 |
Why?
|
| Carbon Isotopes | 1 | 2003 | 458 | 0.050 |
Why?
|
| Half-Life | 1 | 2003 | 652 | 0.050 |
Why?
|
| Twins, Monozygotic | 2 | 2016 | 470 | 0.050 |
Why?
|
| Young Adult | 6 | 2022 | 59207 | 0.050 |
Why?
|
| Food Analysis | 1 | 2021 | 103 | 0.050 |
Why?
|
| Environmental Exposure | 2 | 2022 | 4467 | 0.050 |
Why?
|
| Birth Weight | 1 | 2009 | 2100 | 0.050 |
Why?
|
| Bone Density | 2 | 2018 | 3551 | 0.050 |
Why?
|
| Isomerism | 1 | 2020 | 197 | 0.050 |
Why?
|
| Vegetables | 2 | 2016 | 1196 | 0.040 |
Why?
|
| Anthropometry | 2 | 2018 | 1349 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2006 | 1814 | 0.040 |
Why?
|
| England | 2 | 2011 | 527 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2003 | 2265 | 0.040 |
Why?
|
| Europe | 2 | 2018 | 3423 | 0.040 |
Why?
|
| Sex Factors | 2 | 2017 | 10548 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2011 | 3541 | 0.040 |
Why?
|
| Parathyroid Hormone | 2 | 2018 | 1803 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 1902 | 0.040 |
Why?
|
| Aging | 1 | 2016 | 8705 | 0.040 |
Why?
|
| Valerates | 1 | 2016 | 20 | 0.030 |
Why?
|
| Adolescent | 4 | 2018 | 88313 | 0.030 |
Why?
|
| Femur Neck | 1 | 2018 | 314 | 0.030 |
Why?
|
| Phenol | 1 | 2016 | 44 | 0.030 |
Why?
|
| Depression | 1 | 2016 | 8122 | 0.030 |
Why?
|
| Uridine | 1 | 2016 | 141 | 0.030 |
Why?
|
| Caffeic Acids | 1 | 2015 | 15 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2003 | 2192 | 0.030 |
Why?
|
| Coumaric Acids | 1 | 2015 | 13 | 0.030 |
Why?
|
| Food | 1 | 2020 | 772 | 0.030 |
Why?
|
| Hesperidin | 1 | 2015 | 18 | 0.030 |
Why?
|
| Catechin | 1 | 2015 | 69 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2018 | 970 | 0.030 |
Why?
|
| Menopause | 1 | 2003 | 1646 | 0.030 |
Why?
|
| Quercetin | 1 | 2015 | 97 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2020 | 2851 | 0.030 |
Why?
|
| Spirometry | 1 | 2018 | 928 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2016 | 437 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2006 | 2223 | 0.030 |
Why?
|
| United States | 3 | 2019 | 72339 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2018 | 3110 | 0.030 |
Why?
|
| Endometrial Neoplasms | 1 | 2003 | 1365 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 20093 | 0.030 |
Why?
|
| Quality Control | 1 | 2016 | 832 | 0.030 |
Why?
|
| Micronutrients | 1 | 2016 | 381 | 0.030 |
Why?
|
| Seafood | 1 | 2016 | 393 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 4852 | 0.030 |
Why?
|
| Registries | 1 | 2008 | 8223 | 0.030 |
Why?
|
| Prevalence | 2 | 2021 | 15717 | 0.030 |
Why?
|
| Amino Acids | 1 | 2018 | 1718 | 0.030 |
Why?
|
| Coffee | 1 | 2016 | 593 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 2016 | 891 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2006 | 6391 | 0.020 |
Why?
|
| Multilevel Analysis | 1 | 2011 | 150 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 2016 | 952 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2021 | 2597 | 0.020 |
Why?
|
| Cause of Death | 1 | 2021 | 3684 | 0.020 |
Why?
|
| Vitamin D | 2 | 2018 | 3301 | 0.020 |
Why?
|
| Collagen | 1 | 2018 | 2638 | 0.020 |
Why?
|
| Mortality | 1 | 2021 | 2900 | 0.020 |
Why?
|
| Stilbenes | 1 | 2010 | 155 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2011 | 251 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2011 | 344 | 0.020 |
Why?
|
| Age Factors | 1 | 2006 | 18400 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 2009 | 236 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2003 | 5919 | 0.020 |
Why?
|
| Review Literature as Topic | 1 | 2010 | 347 | 0.020 |
Why?
|
| Peripheral Arterial Disease | 1 | 2019 | 1272 | 0.020 |
Why?
|
| Procollagen | 1 | 2008 | 187 | 0.020 |
Why?
|
| Consumer Product Safety | 1 | 2008 | 122 | 0.020 |
Why?
|
| History, 19th Century | 1 | 2010 | 720 | 0.020 |
Why?
|
| Sulfoxides | 1 | 2006 | 47 | 0.020 |
Why?
|
| Isothiocyanates | 1 | 2006 | 49 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 4287 | 0.020 |
Why?
|
| Nurses | 1 | 2016 | 2478 | 0.020 |
Why?
|
| Comorbidity | 1 | 2021 | 10498 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 6019 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2006 | 465 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2006 | 319 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2016 | 2897 | 0.010 |
Why?
|
| Luciferases | 1 | 2005 | 714 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2005 | 426 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2005 | 731 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2008 | 12330 | 0.010 |
Why?
|
| Caspases | 1 | 2005 | 879 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 687 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8832 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2011 | 6343 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2010 | 2769 | 0.010 |
Why?
|
| Lipoprotein(a) | 1 | 2006 | 480 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14664 | 0.010 |
Why?
|
| Infant | 1 | 2003 | 36205 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 10203 | 0.010 |
Why?
|
| Models, Biological | 1 | 2016 | 9469 | 0.010 |
Why?
|
| Apoptosis | 2 | 2006 | 9488 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2006 | 2076 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 23990 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2005 | 3093 | 0.010 |
Why?
|
| Lung | 1 | 2018 | 9995 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 3823 | 0.010 |
Why?
|
| Estradiol | 1 | 2005 | 1937 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2006 | 2932 | 0.010 |
Why?
|
| Cell Division | 1 | 2005 | 4466 | 0.010 |
Why?
|
| Animals | 2 | 2016 | 168441 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 5775 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2006 | 2908 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 4124 | 0.010 |
Why?
|
| Stroke | 1 | 2019 | 9756 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2009 | 3312 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2009 | 2509 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2011 | 7956 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2003 | 21012 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2008 | 5115 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 12450 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 5727 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 8320 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 5789 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 17644 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 7584 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 7595 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 13009 | 0.010 |
Why?
|
| Insulin | 1 | 2006 | 6602 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 10441 | 0.010 |
Why?
|
| Pregnancy | 1 | 2009 | 29862 | 0.000 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 15941 | 0.000 |
Why?
|
| Child | 1 | 2011 | 80162 | 0.000 |
Why?
|
Concepts
(237)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_